New insulin rival tested in healthy people – no cure in sight
NCT ID NCT07588906
First seen May 23, 2026 · Last updated May 23, 2026
Summary
This early-stage study tested a single injection of a new drug called SHR-3167 against standard insulin glargine in 24 healthy men. The goal was to compare how the body handles blood sugar after each drug, not to treat any disease. No direct benefit to participants was expected, and the results will guide future research.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY SUBJECTS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Bishan Hospital of Chongqing
Chongqing, Chongqing Municipality, 400000, China
Conditions
Explore the condition pages connected to this study.